MiMedx Group, Inc.
NASDAQMiMedx Group reports Q2 results on July 31 with the same broad setup as yesterday's preview — shorts still rebuilding, analyst targets well above the current price, and the stock quietly outperforming its peers over the past month — but one detail has sharpened: the ORTEX short score has continued to tick higher, reaching 47.8 on July 28 from 44.9 just two weeks ago, the steepest…
Snapshot as of 13 Aug 2026
MiMedx Group reports Q2 results on July 31 with the same broad setup as yesterday's preview — shorts still rebuilding, analyst targets well above the current price, and the stock quietly outperforming its peers over…
MiMedx Group reports Thursday with an interesting setup: short interest has climbed steadily over the past two weeks, analyst targets have been cut repeatedly since the start of the year, and the stock is sitting well…
MDXG reports Q1 2026 results on April 30 against a backdrop of unusually bullish options positioning — a sharp reversal from the defensive stance that dominated for weeks. The options signal is the standout heading…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MDXG — free to start on ORTEX.
Sign up for free →Open MDXG on ORTEX